Michael S. Cuffe
CIK 1632835 · EVP and Chief Clinical Officer · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.78M
Companies
1
Total Filings
70
Lifetime Open-Market Net
-$31.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HCA | EVP and Chief Clinical Officer | 35,580 | $387.18 | $13.78M | -$31.92M | 70 | 2026-02-12 |
Recent Filings · Page 2 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-02 | HCA | Mixed | −3,928 | -$981.7K | EDGAR |
| 2023-05-02 | HCA | Sell (S) | −12,556 | -$3.57M | EDGAR |
| 2023-04-26 | HCA | Mixed | +12,556 | -$2.33M | EDGAR |
| 2023-02-22 | HCA | Mixed | +7,928 | -$1.11M | EDGAR |
| 2023-02-01 | HCA | Mixed | −4,450 | -$1.03M | EDGAR |
| 2022-02-23 | HCA | Mixed | +7,182 | -$892.9K | EDGAR |
| 2022-02-01 | HCA | Grant (A) | — | $0 | EDGAR |
| 2021-10-27 | HCA | Grant (A) | — | $0 | EDGAR |
| 2021-08-05 | HCA | Sell (S) | −2,500 | -$629.8K | EDGAR |
| 2021-05-03 | HCA | Mixed | −16,528 | -$4.04M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.